2026/2838(RPS)ENVI

Objection pursuant to Rule 115(2), (3), and (4)(c): maximum residue levels for flupyradifurone

Commission Regulation amending Annex II to Regulation (EC) No 396/2005 of the European Parliament and of the Council as regards maximum residue levels for azoxystrobin, etofenprox, fenpropidin, flupyradifurone, hexythiazox, imazalil, spinosad and tebufenozide in or on certain products

Stage: EP position adopted, reached 16 Sept 2026
Rapporteurs: Anja Hazekamp (The Left), Christophe Clergeau (S&D), Jutta Paulus (Greens/EFA), Martin Hojsík (Renew)
Last activity: 16 Sept 2026

2 entries · record as of 12 Oct 2026

Where it stands

Latest: Plenary vote, 16 Sept 2026.

16 Sept 2026
- Plenary vote
- Referred to committee

4 people

Who is on it

The Parliament's rapporteurs, shadow rapporteurs and opinion rapporteurs currently on this file.

Role	Name	Group	Country	Committee
Co-rapporteur	Anja Hazekamp	The Left	NL	ENVI
Co-rapporteur	Christophe Clergeau	S&D	FR	ENVI
Co-rapporteur	Jutta Paulus	Greens/EFA	DE	ENVI
Co-rapporteur	Martin Hojsík	Renew	SK	ENVI

2 documents

Documents

Newest first. Each opens at its source.

B10-0392/2026Parliament
Text adopted · T10-0295/2026Parliament

Summary

Generated

Parliament adopted an objection under Rule 115(2), (3) and (4)(c) to a Commission draft regulation amending Annex II to Regulation (EC) No 396/2005 on maximum residue levels for flupyradifurone. The draft would also revise MRLs for azoxystrobin, etofenprox, fenpropidin, hexythiazox, imazalil, spinosad and tebufenozide in or on certain products.

What the workspace adds on this file

Everything above is the public record. In the workspace, subscribers see this file with their own layer on top.

Why it matters to you

What this file means for your organization, assessed against your own priorities.

What moved

When this file moves, it reaches your own briefing, with a link to its source.

Your contacts on it

Your team's contacts logged against this file: who you met, what was said and the next step.

A first draft

A statement, a member update or a meeting brief on this file, in your organization's voice, with its sources.

Record as of 12 Oct 2026. Something wrong on this page? Report an error.

Request access

See this file with your own layer on top: why it matters to you, your contacts on it and a first draft. We’ll schedule a 20-minute walkthrough.

Hosted in the EU · Security →

By submitting, you agree to our privacy policy.